OPC-21268 [Ligand Id: 2196] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL296908 (OPC-1268, OPC-21268)
There should be some charts here, you may need to enable JavaScript!
  • V1A receptor/Vasopressin V1a receptor in Human [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288]
  • V1A receptor/Vasopressin V1a receptor in Rat [ChEMBL: CHEMBL2868] [GtoPdb: 366] [UniProtKB: P30560]
There should be some charts here, you may need to enable JavaScript!
  • V2 receptor/Vasopressin V2 receptor in Human [ChEMBL: CHEMBL1790] [GtoPdb: 368] [UniProtKB: P30518]
  • V2 receptor/Vasopressin V2 receptor in Rat [ChEMBL: CHEMBL3766] [GtoPdb: 368] [UniProtKB: Q00788]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
OT receptor/Oxytocin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2049] [GtoPdb: 369] [UniProtKB: P30559]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. B 6.77 pKi 170 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue B 6.77 pKi 170 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
GtoPdb - - 6.8 pKi - - - Life Sci (1995) 57: 2253-61 [PMID:7475979]
OT receptor/Oxytocin receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3996] [GtoPdb: 369] [UniProtKB: P70536]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats B 6.64 pKi 230 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue B 6.64 pKi 230 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
V1A receptor/Vasopressin V1a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets. B 4.28 pKi 52000 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue B 4.28 pKi 52000 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
ChEMBL Binding affinity towards Vasopressin V1a receptor in human liver B 4.85 pKi 14000 nM Ki J Med Chem (2000) 43: 4388-4397 [PMID:11087564]
ChEMBL Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand B 5 pKi >10000 nM Ki J Med Chem (2002) 45: 2589-2598 [PMID:12036368]
GtoPdb - - 5.1 pKi - - - Endocrinology (1997) 138: 4109-22 [PMID:9322919]
ChEMBL Binding affinity to vasopressin V1a receptor B 6.46 pKi 350 nM Ki J Nat Prod (1994) 57: 1329-1335 [PMID:7807119]
V1A receptor/Vasopressin V1a receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2868] [GtoPdb: 366] [UniProtKB: P30560]
ChEMBL Binding affinity towards Vasopressin V1a receptor in rat liver B 7.49 pKi 32 nM Ki J Med Chem (2000) 43: 4388-4397 [PMID:11087564]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver. B 7.49 pKi 32 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue B 7.49 pKi 32 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
ChEMBL Evaluated for the binding affinity towards Vasopressin V1a receptor in rat liver membrane using [3H]AVP as radioligand B 7.63 pKi 23.5 nM Ki Bioorg Med Chem Lett (2002) 12: 229-232 [PMID:11755361]
ChEMBL Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver B 7.63 pKi 23.5 nM Ki J Med Chem (2002) 45: 2589-2598 [PMID:12036368]
ChEMBL Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor) B 6.36 pIC50 440 nM IC50 J Med Chem (1993) 36: 2011-2017 [PMID:8393113]
V2 receptor/Vasopressin V2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1790] [GtoPdb: 368] [UniProtKB: P30518]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in kidney medulla obtained from early postmortem human donors. B 4.09 pKi >81000 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]vasopressin from vasopressin V2 receptor in human kidney tissue B 4.09 pKi >81000 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
GtoPdb - - 4.5 pKi - - - Endocrinology (1997) 138: 4109-22 [PMID:9322919]
ChEMBL Binding affinity at cloned human Vasopressin V2 receptor stably expressed in CHO cells, using [3H]AVP as radioligand B 5 pKi >10000 nM Ki J Med Chem (2002) 45: 2589-2598 [PMID:12036368]
V2 receptor/Vasopressin V2 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3766] [GtoPdb: 368] [UniProtKB: Q00788]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in kidney medulla obtained from rats. B 4.52 pKi >30000 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]vasopressin from vasopressin V2 receptor in rat kidney tissue B 4.52 pKi >30000 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
ChEMBL Evaluated for the binding affinity towards Vasopressin V2 receptor in rat kidney membrane using [3H]-AVP as radioligand B 5 pKi >10000 nM Ki Bioorg Med Chem Lett (2002) 12: 229-232 [PMID:11755361]
ChEMBL Binding affinity at Vasopressin V2 receptor, performed using [3H]AVP on rat kidney B 5 pKi >10000 nM Ki J Med Chem (2002) 45: 2589-2598 [PMID:12036368]
ChEMBL Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V2 receptor) B 4 pIC50 >100000 nM IC50 J Med Chem (1993) 36: 2011-2017 [PMID:8393113]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]